Detalhe da pesquisa
1.
Cerebral Oximetry Monitoring in Extremely Preterm Infants.
N Engl J Med;
388(16): 1501-1511, 2023 Apr 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37075142
2.
Cerebral oximetry monitoring versus usual care for extremely preterm infants: a study protocol for the 2-year follow-up of the SafeBoosC-III randomised clinical trial.
Trials;
24(1): 653, 2023 Oct 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37805539
3.
The effects of cerebral oximetry in mechanically ventilated newborns: a protocol for the SafeBoosC-IIIv randomised clinical trial.
Trials;
24(1): 696, 2023 Oct 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37898759
4.
Extremely Preterm Infant Admissions Within the SafeBoosC-III Consortium During the COVID-19 Lockdown.
Front Pediatr;
9: 647880, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34322460
5.
Cerebral near-infrared spectroscopy monitoring versus treatment as usual for extremely preterm infants: a protocol for the SafeBoosC randomised clinical phase III trial.
Trials;
20(1): 811, 2019 Dec 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31888764
6.
Detailed statistical analysis plan for the SafeBoosC III trial: a multinational randomised clinical trial assessing treatment guided by cerebral oxygenation monitoring versus treatment as usual in extremely preterm infants.
Trials;
20(1): 746, 2019 Dec 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31856902